Welcome to Crene Biotechnology!

+86-576-88205808

Product :

Lenvatinib mesylate

Lenvatinib mesylate 857890-39-2
Size Price Stock Quantity
Get Quotation Now Add to Cart Bulk Inquiry
Shipping and handling fee USD40, Free delivery is qualified when the total value of your order exceeds USD500.If the item is temporarily out of stock. Please email to order@pharm-intermediates.com,we will inform you when we have it in stock.
Chemical Information
Product name:Lenvatinib mesylate Purity:98% min
CAS NO:857890-39-2 Solubility:DMSO: 9 mg/mL (17.2 mM)
Molecular Formula:C22H23ClN4O7S Package:Package according to customer requirements
Molecular Weight:522.959 Storage:Store at -20℃
Quality control
COA
Remarks

Lenvatinib, also known as E7080, is a synthetic, orally available inhibitor of vascular endothelial growth factor receptor 2 (VEGFR2, also known as KDR/FLK-1) tyrosine kinase with potential antineoplastic activity. E7080 blocks VEGFR2 activation by VEGF, resulting in inhibition of the VEGF receptor signal transduction pathway, decreased vascular endothelial cell migration and proliferation, and vascular endothelial cell apoptosis.

 

Lenvatinib Mesylate (E7080) is a synthetic, orally available tyrosine kinase inhibitor that inhibits vascular endothelial growth factor receptor (VEGFR1-3), fibroblast growth factor receptor (FGFR1-4), platelet-derived growth factor receptor α (PDGFRα), stem cell factor receptor (Kit (c-Kit)), and rearranged during transfection (RET (c-RET)). Lenvatinib Mesylate has potential antineoplastic activity.

 

 

 

FGFR Inhibitors Related Products:

Infigratinib; PD173074; AZD4547; Danusertib; Brivanib alaninate; Pemigatinib; Lenvatinib; Nintedanib esylate; BLU9931; SKLB610; Roblitinib

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Friendly link:

Copyright Copyright (C) 2018-2024 Taizhou Crene Biotechnology Co.,Ltd.  

Address:Economic Developed Zone of Taizhou Zhejiang China